Literature DB >> 25655300

Blunt abdominal injury with rupture of giant hepatic cavernous hemangioma and laceration of the spleen.

Lung-Yun Kang1, Fong-Dee Huang, Yuan-Yuarn Liu.   

Abstract

A 41-year-old woman with blunt abdominal trauma due to a motor vehicle accident presented to our emergency department. The patient had a history of a giant hepatic cavernous hemangioma. Emergency exploratory laparotomy was performed for suspected intra-abdominal bleeding with abdominal compartment syndrome, and more than 4 liters of blood and blood clots were removed. An active bleeding laceration (5 cm) of a hepatic cavernous hemangioma was detected in segment III of the liver. The bleeding was controlled by sutures, Teflon patches and tamponade. The abdomen was closed temporarily using the vacuum-assisted method. Because of the presence of persistent fresh blood through abdominal drainage at a rate of >1 L/h, splenectomy was performed to control the bleeding again by sutures and Teflon patches. Finally, the abdomen was closed using a biologic mesh. The patient was discharged home 30 days after trauma. Bleeding of trauma-caused hepatic hemangioma is rare, but splenic injury due to blunt abdominal trauma is common. An in-depth investigation is necessary to avoid second intervention.

Entities:  

Mesh:

Year:  2015        PMID: 25655300     DOI: 10.1016/s1499-3872(14)60310-6

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

1.  [Value of clinical key symptoms in the primary treatment of severely injured patients].

Authors:  S Piatek; G Pliske; A Ballaschk; K Witzel; F Walcher
Journal:  Unfallchirurg       Date:  2015-08       Impact factor: 1.000

2.  An Effective Method for Controlling Bleeding in a Ruptured Hepatic Hemangioma: A Case Report.

Authors:  Mohammad Talebpour; Hossein Zabihi-Mahmoudabadi; Pooya Payandemehr; Maryam Momen; Zahra Zali
Journal:  Adv J Emerg Med       Date:  2018-12-02

3.  Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Bodil Bjerkehagen; Ingvild Lobmaier; Sverre Heim
Journal:  Int J Oncol       Date:  2015-12-28       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.